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Foreword 
The Laboratory of the Water and Marine Resources Unit investigates the occurrence and 
fate of chemical pollutants entering and travelling with the natural and urban water 
cycles. In doing so, the laboratory also characterises the possible treatment and removal 
options for such compounds. In particular the so-called Compounds of Emerging Concern 
(CECs) as well as their degradation and metabolisation products are of interest in its 
investigation. 
The issue of veterinary medicinal products and in particular those of an antimicrobial 
effect have attracted interest while trying to understand the development and 
propagation of antimicrobial resistances. 
In order to improve the knowledge base the laboratory prepares an EU-wide assessment 
on waters exposed directly or indirectly to manure and derived fertilising products. 
Particular attention is given to the investigation of agricultural runoff, but also to the 
question to which extend such chemicals will enter either the food chain or other supply 
chains in case of reuse of the manure. 
The findings will be published in a series of technical reports in which this one is the first 
stepping-stone in building an enhanced knowledge base for the making and 
implementation of improved EU policies. 
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Abstract 
In a thinking of circular economy, the understanding of how problematic chemical 
substances may migrate and travel across the various boundaries of a life-cycle is of 
pivotal importance to ensure that the philosophy of reuse and recycle is not jeopardized 
by new risks of contamination. 
In this framework, veterinary medicinal products (VMP) and in particular the anti-
microbial agents (AMAs) are a growing source of concern in the context of the reuse of 
processed manure as a fertilizer. This is mainly due to lack of understanding of their role 
in the development of anti-microbial resistances and their propagation. While the 
mechanistic study on how the propagation takes place at molecular genetic level receives 
much attention, the actual data situation on occurrence of VMPs and AMAs in agricultural 
land remains opaque and poor. 
In order to prepare a larger and EU-wide monitoring exercise on the waters exposed 
directly or indirectly to the (processed) manure a first pilot exercise was organised to 
develop an appropriate protocol. This first report compiles a series of background 
information collected. It describes the execution of first pilot sampling and presents the 
first elements in the development of validated analytical methods. 
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1 Setting the scene 
1.1 General introduction and remarks 
It cannot be denied that the targeted use of chemistry has played an important role in 
the development of an efficient and productive modern agriculture. Until the end of the 
last century the main environmental concern on the adverse effects of chemical use was 
focussed on the impact of traditional chemicals such as heavy metals and persistent 
organic pollutants, but in the past two decades focus has turned to other compound 
classes, commonly re-grouped under the heading "compounds of emerging concern 
(CECs)" or more dramatically "emerging pollutants". The reasons for this development 
are fundamentally two, i.e. on one side a significantly improved analytical capability to 
detect and quantify even at extreme low concentrations those chemical structures, which 
were invisible until then, as well as a growing understanding about how substances alone 
or in combination affect biological processes. Likewise the investigation of the various 
transfer pathways have become the subject in a steadily increasing number of scientific 
publications. 
Figure 1 visualises the possible entry pathways to the agricultural environment of such 
compounds, traditionally stemming from a targeted application in crop and plant 
protection and management, the reuse of (treated) bio-waste, sewage sludge or 
reclaimed wastewater in agriculture as well as the processes involved in livestock use 
and meat production (Boxall, 2012). In particular, the use of untreated manure or in 
more or less strongly processed form has not been sufficiently investigated with regard 
to their potential release of pharmaceuticals and agents of an anti-microbial activity into 
the aquatic environment (Thanner et al., 2016). 
 
Figure 1 - Entry pathways of CECs into the agricultural environment  
 
In this framework, veterinary medicinal products (VMP) and in particular the anti-
microbial agents are a growing source of concern, mainly due to their role in the 
development of anti-microbial resistances and their propagation. While the mechanistic 
study on how the propagation takes place at molecular genetic level receives much 
attention, the actual data situation on occurrence of VMPs and AMAs in agricultural land 
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remains opaque and poor. Laboratory studies are usually referring to unnatural 
conditions, extreme scenarios or do not reflect typical European conditions. Likewise, the 
use of (treated) biosolids such as sewage sludge, compost or digestates as well as the 
employment of animal manure as mineral fertilizer substitute, experiences a renaissance 
with the strong commitment of the EU towards a circular economy approach. In addition, 
manure-derived digestates after a first energy recovery are investigated as nutrient 
integrated resource recovery employing e.g. algae, thus enhancing and improving the 
recovery and reuse aspects by unprecedented technologies (Głowacka et al., 2017)  
Establishing the agronomic value of such fertilizer alternatives requires to assess the 
contamination risk for surface and groundwater. This equally applies to untreated or 
processed manure, sewage sludge or other biowastes. Physico-chemical characteristics of 
VMPs/AMA and of the matrix (manure) of interest must be taken into consideration, too. 
For instance, adverse effects of polluted runoff needs to be understood to mitigate the 
risk that those substances cross the ground barrier and reach the connected water 
bodies. 
Boxall (2012) reviewed carefully the fate and transport processes for CECs in the 
agricultural soil environment, stating that "once released an CEC will experience the 
same fate and transport process that occur of other classes of agricultural contaminants" 
(Fig. 2). 
 
Figure 2 – Overview on the transformation processes to be considered for CECs in 
agricultural soils (Modified from Boxall, 2012) 
1.2 The EU Water Acquis to be considered 
The European Water Framework Directive and its daughter directives span the legal 
framework when it comes to the chemical and ecological status assessment of European 
water bodies. To this end, the WFD introduced a general requirement for ecological 
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protection, and a general minimum chemical standard, to cover all surface waters. The 
targeted "good chemical status" has in this context been defined in terms of compliance 
with all the quality standards established for chemical substances at European level. The 
Directive also provides a mechanism for renewing these standards and establishing new 
ones by means of a prioritisation mechanism for hazardous chemicals. Obviously, the 
process of such identifying substances as well as the sheer number of substances for 
which the so-called environmental quality standards (EQS) can be defined is limited. 
The case of groundwater is somewhat different. The presumption in relation to 
groundwater should broadly be that it should not be polluted at all. For this reason, 
setting chemical quality standards may not be the best approach, as it gives the 
impression of an allowed level of pollution to which Member States can fill up. A very few 
such standards have been established at European level for particular issues (nitrates, 
pesticides and biocides), and these must always be adhered to. But for general 
protection, a precautionary approach has been chosen. 
 
Figure 3 – Components of an optimal processing of pig slurry (modified from EC 2010) 
 
In the context of manure management and the assessment of its environmental impact 
versus agronomic benefit, the most relevant legal instrument is presumably the Nitrates 
Directive. The Nitrates Directive1 (ND) aims at protecting water from diffuse pollution 
(nitrates and eutrophication) from agricultural activity. To this end, the directive 
establishes restrictions on use of nitrogen containing fertilising materials2 in areas with 
                                          
1 Council Directive of 12 December 1991 concerning the protection of waters against pollution caused by 
nitrates from agricultural sources (91/676/EEC) 
2 It is to be noted that the Nitrates Directive and Fertilisers Regulation (EC 2003/2003) use a different definition 
and spelling for a similar word. Under the Nitrates Directive, a fertilizer, spelled with a Z, is defined as any 
nitrogen containing substance utilized on land to enhance growth of vegetation. Under the Fertilisers 
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nitrates pollution in waters (Nitrates Vulnerable Zones-NVZ). Manure and manure-based 
fertilisers are subject to more stringent restrictions than nitrogen containing 
mineral/chemical fertilisers. More specifically, in NVZ the ND restricts the use of manure, 
including processed manure, to 170 kg of N/hectare per year. This maximum limit for 
manure based fertilising materials in polluted areas is based on the consideration that the 
associated environmental risk, especially nitrogen leaching risk, is higher for manure 
than for other fertilisers.  
In line with the objectives of the Circular Economy Action Plan, there is an opportunity to 
encourage recycled nutrients that can replace nutrients from primary raw materials. As 
shown in Fig. 3 for the example of pig production and the related generation of pig 
manure, the main challenge is to obtain recycled nutrient resources that have an equal or 
better environmental performance than the primary nutrient resources they potentially 
could replace. 
Efforts are on-going across the EU to develop manure processing technologies that allow 
turning manure into a safe and agronomical valuable resource that could be more widely 
used in NVZ. The challenge remains on how to apply scientifically sound criteria to ensure 
the agronomic and environmental performance of these new materials. 
It is clear that these criteria can only be developed by gaining a sound knowledge on the 
specific chemical compounds, which are closely related to animal husbandry in 
agricultural context, namely veterinary medicinal and anti-microbial agents or 
accompanying products. 
1.3 Manure processing technologies 
The proposed revision of the Regulation (EC) No 2003/20033 under the Circular Economy 
Action Plan, has seen a scope extension from purely mineral fertilisers to organic 
fertilisers. This could include materials partially or entirely processed from manure, as 
well as fertiliser blends with varying amounts of mineral and organic nutrient forms. This 
means that the definition in the original Nitrates Directive of a "chemical fertilizer" ("any 
fertilizer which is manufactured by an industrial process") and that of a "livestock 
manure" ("waste products excreted by livestock or a mixture of litter and waste products 
excreted by livestock, even in processed form") and their differences are in some cases 
becoming more and more blurred. 
Therefore, action is needed to ensure that the on-going technological and market 
developments for the recycling of nutrients can be reconciled with the continued 
objective of protecting water bodies against pollution originating from manure. 
The agronomic but also environmental value of such technology can only be understood 
if expected environmental risks are assessed properly and set against the economic 
potential. To do so, it is essential that the usual various technologies of processing 
manure are modelled/tried in various combinations and thus delivering a variety of 
output materials of differing properties (Fig. 4). While the technologies are fairly well 
described regarding technological aspects and regarding the fertilizing characteristics of 
the derived processed manure, it is largely unknown what happens to the VMP/AMAs 
stemming from animal husbandry and the related manure. 
A first inventory of manure-processing technology, as well as an economic and 
environmental feasibility assessment were commissioned by DG ENV in 2010 (Foged et 
al., 2011a, 2011b; Flotats et al., 2011). The different processing technologies can be re-
grouped in three main categories, i.e. separation techniques, anaerobic digestion and 
                                                                                                                                 
Regulation, fertiliser, spelled with an S, has a wider definition of a material, the main function of which is to 
provide nutrients to plants. These nutrients can be N but also P, K, Ca, Mg, Na, S, B, Co, Cu, Fe, Mn, Mo or 
Zn. For clarity purposes, this document applies by default the spelling and definition from the Fertilisers 
Regulation and explicitly states when fertilisers are assumed to contain nitrogen. The spelling with z is only 
maintained for direct references to definitions from the Nitrates Directive. 
3 Regulation (EC) No 2003/2003 of the European Parliament and of the Council of 13 October 2003 relating to 
fertilisers 
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alteration by additives and further physicochemical treatment (Fig. 4). According to the 
study findings the overwhelming part of treatment takes place at farm level and only at 
significantly larger scale in small/medium4 size installation or large-scale5 plants. The 
same investigation concluded that in total 7.8% of the livestock manure production in the 
EU is being processed, equal to 108 million tons, containing 556 000 tons of nitrogen and 
139 000 tons phosphorus. 168 million tons livestock manure and other products are 
processed, whereof around 60 million tons (168 minus 108 million tons) are end and by-
products from other processes and non-livestock manure biomasses. The largest share of 
the livestock manure production is processed in Italy, Greece and Germany, with 36.8, 
34.6 and 14.8% respectively (Table 1). 
 
Table 1 – Overview on technologies used for livestock manure treatment in the Member 
States (data from Foged et al., 2011a) 
Technology Farm size 
installations 
Small/medium 
size installation 
Large-scale 
installation 
Amount in 
1000 tons 
% of livestock 
manure treated  
in observed 
member states 
Separation 10 935 120 75 43 383 3,1
Additives and other 
pre/1st treatment 
606 44 18 5 877 0,4
Anaerobic treatment 4 692 459 105 49 033 3,5
Solid fraction treatment 1 254 169 63 7 422 0,5
Liquid fraction Treatment 407 121 59 2 149 0,2
Air cleaning in manure 
processing plant* 
0 30 39 0 0
TOTAL 17 894 943 359 107 864 7,8
 
Flotats et al. (2011) identified 45 processing technologies as standalone technologies or 
belonging to combined treatment systems, which have been categorised as follows: 
• Separation techniques: System with the objective of separating manure into 
two flows: a concentrate (solid fibre fraction) and a diluted fraction (liquid 
fraction). 
• Additives and other pre/1st treatments: Set of processes which have the 
objective to prepare the material for a further purpose or treatment. 
• Anaerobic treatment: Series of biological processes in which microorganisms 
break down organic molecules in absence of oxygen, resulting in the production of 
a mixture of gases, named biogas, mainly composed of methane and carbon 
dioxide.  
• Treatment of the fibre/solid fraction: Processing methods especially suitable 
for solid manures or solid fractions obtained after separation. 
• Treatment of the liquid fraction: Processing methods especially suitable for 
much diluted manures or liquid fractions obtained after separation. 
                                          
4 treating up to 50 000 tons of manure per year 
5 treating more than 50 000 tons of manure per year 
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• Air cleaning (as part of manure processing plant): Methods applied to clean 
process air used during some manure treatment (i.e. exhaust air from 
composting). 
 
Figure 4 – Overview of manure processing technologies 
 
Although the 45 unitary processes identified could be theoretically combined and 
integrated in different ways in a given facility, the fact is that only few combinations or 
groups of combinations are possible and interesting for building a technological 
strategy fitting a given objective.  
 
1.4 Medicinal veterinary products in manure 
"Veterinary medicinal products (VMPs) are excreted by the treated animals in the form of 
unchanged parent substances and metabolized compounds. The excrements from stabled 
animals are usually collected and stored mainly as liquid or solid manure before they are 
used as fertilizers on arable land and grassland. Biocides, which are used for the 
disinfection of stables, end up in the stored animal excrements. Via manure application in 
agriculture, veterinary medicines and biocides are hence released into the environment 
and consequently affect soil and water quality" (Wohde et al., 2016) (Fig. 5). When 
considering the risk of contamination of surface and groundwater adjacent to lands 
fertilised with animal manure or biosolids, both physico-chemical characteristics of 
VMP/AMA and of the matrix (manure) of interest must be considered. Polluted runoff, 
caused by rainfalls or snowmelt or even irrigation, moves over and through the ground 
and carries natural and human-made pollutants that can potentially reach surface water 
and the underground source of drinking water. 
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Figure 5 –Relevant entry pathways of VMP via manure into the environment 
 
In a study report prepared for the Executive Agency for Health and Consumers a 
comparison was made between medicinal products used for humans and veterinary 
applications (BIO Intelligence Service, 2013). In general, veterinary medicinal products 
were reported to be used in smaller quantities than human medicinal products. 
Veterinary medicinal products are extensively used in farming for therapeutic and 
metaphylactic purposes, which represent more than 95% of the use of medicines in the 
rearing of piglets and turkey, more than 70% of the use of medicines for pigs and poultry 
and 30% of the use of medicines for bovine (Kools et al., 2008). Some commonly used 
treatment practices, such as campaign treatment of all animals in the farm, need very 
high quantities of veterinary medicinal products. For example, if 1 000 cows or 10 000 
pigs or 100 000 poultry are treated through feed, the quantities of the used preparation 
of veterinary medicinal products in the campaign may be remarkably high. The types of 
medicinal products used and prescribing patterns (dosage, length of treatment periods 
and formulation) may vary significantly for the various species in different countries, as 
for antimicrobials (EMA, 2010). 
The same study also quotes that in Germany for instance, 98% of the antibiotic APIs 
(Active Pharmaceutical Ingredient) in veterinary medicines are used for treating pigs and 
poultry, while the remaining 2% are spread among other species. In Belgium on the 
other hand, cattle farming is a major consumer of antimicrobial agents. According to our 
knowledge still today, there is no overall EU picture regarding these figures. EMA 
however, reviewed again in 2014 reported sales figures for veterinary antimicrobial 
agents in 29 European countries (EMA, 2014). The EMA report concluded that in EU-27 
plus Switzerland and Iceland, the total amount of active ingredients used primarily for 
food producing animals passed 9 000 tons, of which more than 60 per cent where 
consumed in three countries (Spain, Italy and Germany). 
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1.5 Compound classes and compounds used most frequently and 
the situation in the EU 
Medicinal products for veterinary use, have to be authorised either at Member State or 
Community level before they can be placed on the Medicinal products for veterinary use, 
just like medicinal products for human use, have to be authorised either at Member State 
or Community level before they can be employed in the European Union. 
The following section is retrieved of the Commission´s homepage informing about the 
state of play (https://ec.europa.eu/food/animals/health/regulation_en): 
 
 
“The first objective of the European legislation is to protect public and animal health. 
The second objective is the completion of the internal market for pharmaceutical 
products. Particular special rules are applied to ensure consumer protection from 
residue limits from pharmacologically active substances used in food-producing 
animals. 
The Commission is considering a revision of the legal framework for veterinary 
medicinal products. On 10 September 2014 the European Commission has adopted a 
pair of proposals on veterinary medicinal products and medicated feed. The proposal 
on veterinary medicinal products aims to: 
• Increase the availability of veterinary medicinal products; 
• Reduce administrative burden; 
• Stimulate competitiveness and innovation; 
• Improve the functioning of the internal market; and 
• Address the public health risk of antimicrobial resistance. 
 
In 2016, the European Parliament and the Council adopted the Regulation on 
transmissible animal diseases (“Animal Health Law”).  
Overall, the single, comprehensive new animal health law will support the EU livestock 
sector in its quest towards competitiveness and safe and smooth EU market of animals 
and of their products, leading to growth and jobs in this important sector: 
• The huge number of legal acts are streamlined into a single law 
• Simpler and clearer rules enable authorities and those having to follow the 
rules to focus on key priorities: preventing and eradicating disease 
• Responsibilities are clarified for farmers, vets and others dealing with animals 
• The new rules allow greater use of new technologies for animal health activities 
- surveillance of pathogens, electronic identification and registration of animals  
• Better early detection & control of animal diseases, including emerging 
diseases linked to climate change, will help to reduce the occurrence and 
effects of animal epidemics 
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The following tables give a general overview on typical and frequently used compounds in 
veterinary applications. The review is neither complete nor claims any form of full 
representativeness or specific applicability for the EU. The information was compiled to 
facilitate the development of appropriate analytical protocols for the scope of this study. 
It has to be stressed that brand names appearing in this article are examples only. No 
endorsement is intended, nor is criticism implied of similar products not mentioned. 
Some of the compounds listed may be banned or restricted in the EU or single Member 
States and have been considered only for analytical methodology development purposes.  
 
• There will be more flexibility to adjust rules to local circumstances, and to 
emerging issues such as climate and social change 
• It sets out a better legal basis for monitoring animal pathogens resistant to 
antimicrobial agents supplementing existing rules and two other proposals 
currently being negotiated in the European Parliament and Council, on 
veterinary medicines and on medicated feed 
 
The animal health law is part of a package of measures proposed by the Commission 
in May 2013 to strengthen the enforcement of health and safety standards for the 
whole agri-food chain. It is the biggest and the first of those to get the approval of the 
co-legislators. The animal health law is also a key output of the Animal Health 
Strategy 2007-2013, "Prevention is better than cure".  
Several delegated and implementing acts will be adopted by the Commission until 
April 2019 to make the new rules applicable. The Commission will duly consult 
experts, Member States and other interested parties, EU stakeholders (e.g. in the 
Animal Health Advisory Committee) during the drafting of these delegated and 
implementing acts, in the spirit of better regulation.” 
  
14 
Table 2 – Overview on selected active pharmaceutical ingredients, compounds and veterinary medicinal products used in poultry, swine, 
dairy and sheep industries 
Compound class Examples Comments 
 Poultry Production  
Antibiotics Bacitracin (e.g., BMD, Pennitracin MD, Albac), 
Ionophores, Chlortetracycline (e.g., Chloratet, 
Aureomycin), Lincomycin (e.g., Lincomx), 
Oxytetracycline (e.g., Terramycin), Penicillin, Tylosin 
(e.g., Tylan), Virginiamycin (e.g., Stafac, V-Max) 
Antibiotics are used in poultry production not only for therapeutic purposes; some 
producers also administer sub-therapeutic dosages for growth promoting 
purposes, and residues can be detected in eggs and poultry meat if proper 
withdrawal protocols are not followed. Furthermore, zoonotic bacteria may acquire 
resistance to antibiotics as a result of administration of sub-therapeutic dosages 
(Diaz-Sanchez et al., 2015). 
Coccidiostats Amprolium (e.g., Amprol, Corid), Bambermycin (e.g., 
Flavomycin, GAINPRO), Decoquinate (e.g., Deccox), 
Diclazuril (e.g., Clinacox), Halofuginone hydrobromide 
(e.g., Stenorol), Lasalocid (e.g., Avatec), Monensin 
(e.g., Coban), Narasin (e.g., Monteban), Nicarbazin 
(e.g., Nicarb 25%), Salinomycin (e.g., Bio-Cox, 
Sacox), Semduramicin (e.g., Aviax), Sulfadimethoxine 
and ormetoprim 5:3 (e.g., Rofenaid) 
Coccidiosis is a common parasitic disease of poultry and important from an 
economic point of view in poultry industry (Kant et al., 2013) It is the result of an 
infestation of coccidia in the intestines. The agents used for the prevention and 
control of coccidia infections are termed as anticoccidial drugs. The agents which 
destroy the coccidial population are termed as coccidiocidal and agents which 
prevent the replication and growth of coccidial population are known as 
coccidiostatic. 
Medications for 
controlling intestinal 
worms 
Fenbendazole—for turkeys only (e.g., Safe-Guard), 
Hygromycin B—for chickens only (e.g., Hygromix-8) 
There are several types of parasitic worm that can infest poultry, including 
roundworm, tapeworm, cecal worms, and capillary worms. There are only a few 
products that can be added to conventional poultry feed to control internal 
parasites. No products are approved for use with egg-laying hens. 
Products for Controlling 
External Parasites 
Permethrin-based medications (e.g., Prozap Garden 
and Poultry Dust), Tetrachlorvinphos-based 
medications (e.g., Rabon), Carbaryl-based medications 
(e.g., Sevin - voluntarily withdrawn for use with 
poultry) 
Typical external parasites of poultry include mites, lice, fleas, and ticks 
Products for Controlling 
Darkling Beetles 
Imidacloprid (Brand name: CREDO) 
Cyfluthrin (Bfrand name: TEMPO)  
Darkling beetles are a common problem in poultry facilities. The adults are black 
with hardened front wings and antennae that start under a ridge near the eyes. 
The larvae (referred to as mealworms) are worm-like and slightly hardened for 
burrowing. Both the larvae and beetles eat decaying leaves, sticks, grass, dead 
insects, faeces, and grains. 
Products for Fly Control Cyromazine (e.g., Flyzine, Larvadex, and Solitude IGR)  
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Compound class Examples Comments 
 Swine industry  
Antibiotics Amoxicillin, Ampicillina, Apramycin, Arsenilic acid, 
Bacitracin, Bambermycins, Chlortetracycline, 
Efrotomycin, Erythromycin, Gentamycin, Lincomycin, 
Neomycin, Oleandomycin, Oxytetracycline, Penicillin, 
Spectinomycin, Streptomycin, Tetracycline, Tiamulin, 
Tylosin, Virginiamycin 
Antibiotics are typically used in hogs to treat various infections or increased growth 
and feed efficiency (Source Compendium, 1997, Source: Compiled from FDA 
Approved Animal Drug List (Green Book), 1998a, and Feed Additive) 
Chemotherapeutics used 
for hogs 
Arsanilate sodium, Arsanilic acid, Carbadox, 
Roxarsone, Sulfaethoxypyridazine, 
Sulfachlorpyidazine, Sulfamethazine, Sulfathiazole 
Unlike antibiotics, which aim specifically on bacteria, chemotherapeutics kill body 
cells. 
 Dairy industry  
Antibiotics Amoxicillin, Ampicillin, Bacitracin, Ceftiofur, 
Cephapirin, Chlortetracycline, Cloxacillin, 
Dihydrosteptomycin, Erythromycin, Furamazone, 
Gentimycin, Hetacillin, Lasalocida, Monensinc, 
Neomycin, Novobiocin, Oxytetracycline, Penicillin, 
Pirlimycin, Streptomycin, Tetracycline, Tilmicosin, 
Tylosin 
 
Sulfonamides Sulfabromomethazine, Sulfachloropyridazine, 
Sulfadimethoxine, Sulfaethoxypyridazine, 
Sulfamethazine, Sulfamethoxine 
 
Steroid Products Estradiol, Estradiol/Progesterone, 
Estradiol/Testosterone, Estradiol/Trenbolone, 
Melengestrol, Trenbolone, Zeranol 
 
 The sheep industry  
Antibiotics Chlortetracycline, Erythromycin, Neomycin, 
Oxytetracycline, Penicillin, Penicillin/Streptomycin 
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Table 3 – Examples of selected active pharmaceutical ingredients, compounds and veterinary medicinal products used for Minor Species 
Species Compound/Active ingredient Claims 
Reindeer Ivermectin Grubs 
Duck Chlortetracycline Growth, feed efficiency, various infections 
  Novobiocin Various infections 
Goat Decoquinate Coccidiosis 
  Monensin Coccidiosis 
  Neomycin Enteritis 
  Penicillin/ streptomycin Various infections 
  Phenothiazine Worms 
  Thiabendazole Worms 
Pheasant Amprolium Coccidiosis 
  Bacitracin Growth, feed efficiency, various infections 
  Penicillin Growth, feed efficiency 
  Thiabendazole Worms 
Quail Bacitracin Growth, feed efficiency, various infections 
  Monensin Coccidiosis 
  Penicillin Growth, feed efficiency 
Rabbits Penicillin/ streptomycin Various infections 
  Sulfaquinoxaline Coccidiosis 
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Table 4 – Examples of selected active pharmaceutical ingredients, compounds and veterinary medicinal products used in aquaculture 
 
Drug Active Ingredient Indication Species 
Finquel, MS-222 Tricaine methanesulfonate Sedation/anesthesia Fish (Ictaluridae, Salmonidae, 
Esocidae, Percidae), other aquatic 
poikilotherms 
Formalin-F; 
Paracid-F; 
Parasite-S 
Formalin Control protozoa and monogenetic trematodes (Icthyopthirius, Chilodonella, 
Costia, Scyphidia, Epistylis, Trichodina spp. and Cleidodiscus, Gyrodactylus, 
Dactylogyrus spp.) 
Salmonids, catfish, largemouth 
bass, bluegill 
    Control fungi of the family Saprolegniaceae Salmodi and esocid eggs 
Parasite-S Formalin Control protozoan parasites (Bodo spp., Epistylis spp., and Zoothamnium spp.) Panaeid shrimp 
Romet-30 Sulfadimethoxine and 
ormetoprim 
Control furunculosis (Aeromonas salmonicida) Salmonids 
    Control enteric septicemia (Edwardsiella ictaluri) Catfish 
Terramycin Oxytetracycline monoalkyl 
trimethyl ammonium 
Mark skeletal tissue 
Control ulcer disease, furunculosis, bacterial hemorrhagic septicemia, and 
pseudomonas disease (Hemophilus piscium, Aeromonas salmonicida, 
Aeromonoas liquefaciens, Pseudomonas) 
Pacific salmon 
Salmonids 
    Control bacterial hemorrhagic septicemia and pseudomonas disease Catfish 
    Control gaffkemia (Aerococcus viridans) Lobster 
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1.6 Manure storage in the EU 
In the context of compiling agro-environmental indicators (AEI), DG EUROSTAT assessed 
the management of manure in the EU with a focus on trends in manure storage facilities 
in agricultural holdings (Table 5). The indicator is primarily of relevance for the agri-
environmental indicator AEI 18 - Ammonia emissions and nutrient leaching losses from 
animal manures. 
 
Table 5 - Holdings with manure storage facilities, EU-27 and NO6 
                                          
6 Source: Eurostat, http://ec.europa.eu/eurostat/statistics-explained/index.php/File:Holdings_with_manure_storage_facilities,_EU-
27_and_NO,_2003.jpg 
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It is measured by the following indicators: 
• Share of holdings with livestock which have manure storage facilities in total 
holdings with livestock. 
• Share of holdings with different manure storage facilities. 
 
According to the collected information the number of holdings with manure storage 
facilities in EU-27 increased from 2.0 to 2.2 million between 2003 and 2010. In 2010, 
33% of the holdings with livestock in EU-28 had storage facilities for manure. 
At country level there were however large differences: while in Austria, Slovakia, Sweden 
and Switzerland almost all holdings with livestock had manure storage facilities, in 
Bulgaria and Cyprus almost none of the holdings with livestock had manure storage 
facilities. 
While in EU-28 only 14% of the holdings with manure storage facilities for solid dung 
used a cover to protect emissions to air and water in 2010, this was the case for 87% of 
the holdings which had manure storage facilities for liquid manure and for 69% of the 
holdings with manure storage facilities for slurry. 
Data on manure storage and related information on animal housing and manure 
application techniques are available for all EU-28 Member States from a special one-off 
survey carried out in 2010, namely the Survey on agricultural production methods 
(SAPM). 
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2 Towards an EU-wide pilot-campaign 
As indicated by the information collected in Chapter 1 of this report, understanding the 
role of agricultural application of manure in the propagation of anti-microbial resistances 
(AMR), the interspecies exchange or antibiotic-resistant genes as well as the role of 
veterinary antimicrobial agents is a priority field of research. There is still a significant 
data gap on the drainage from lands that have been irrigated with treated wastewater or 
that have been fertilised directly with animal manure or derived biosolids (e.g. after 
digestion). Veterinary medicinal products (VMPs), many of which administered as 
antimicrobial agents (AMA) are excreted by the treated animals in the form of unchanged 
parent substances and metabolized compounds. The excrements from stabled animals in 
Europe and North America are collected and stored mainly as liquid or solid manure 
before they are used as fertilizers on arable land and grassland. Biocides, which are used 
for the disinfection of stables, end up in the stored animal excrements. Via manure 
application in agriculture, the veterinary medicines and biocides are released into the 
environment and consequently affect soil and water quality. Questions on the spatial 
occurrence and fate of these compounds, as well as of their metabolization and 
degradation compounds remain open and only sporadic studies with selected applications 
exist. An EU-wide analyses of the environmental impact has not been undertaken and 
existing case studies are of limited comparability due to the different methodological 
approaches chosen. 
To address these questions properly, the collection of EU-wide data sets are of utmost 
importance, e.g. for the subsequent development of modelling scenarios (Pistocchi et al. 
2010, 2012). Gawlik et al. (2012) as well as Loos et al.  (2009, 2010) successfully 
developed and tested an appropriate approach to deliver such data sets for compounds 
of emerging concern. 
The advances made by the JRC Exploratory research Programme lead to the 
development of a robust and reliable sampling device allowing the onsite-extraction and 
stabilisation of compounds of emerging concern such as the aforementioned AMAs and 
VMPs (Mariani et al., 2017). In order to develop an appropriate testing protocol, which 
combines the features of the MARIANI-Box as well as elucidates the transfer and fate 
pathways of active pharmaceutical ingredients used in livestock applications a first 
exploratory pilot campaign was conducted in November 2017. 
2.1 Objectives of the exploratory pilot sampling 
When addressing the risk of contamination of surface and groundwater adjacent to lands 
fertilised with animal manure or biosolids, both physico-chemical characteristics of 
AMA/VMP and of the matrix (manure) of interest must be accounted for. Polluted runoff, 
caused by rainfalls or snowmelt or even irrigation, moves over and through the ground 
and carries natural and human-made pollutants that can potentially reach surface water 
and the underground source of drinking water. 
An appropriate test site for the development of a protocol needed hence to consider the 
following aspects: 
• Access to manured lands and information on current manure application practices. 
• Manure characterisation (i.e.: kind of manure (solid or liquid), manure storage 
temperature and time, manure dry matter content, timing of application, etc.). 
• Availability of information on manure application techniques, weather data, 
farming and livestock. 
• Access to water samples in surface ditches and/or drainage tile channels 
surrounding the manured soil. 
• Access to the underground water wells (if available). 
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• Development of extraction and analytical method for non-processed and 
processed manure samples. 
The primary objective of the first exploration was hence to define a realistic sampling 
scenario, which could be repeated at several occasions in other EU sites. It needed to be 
tested to which extent the sampling equipment can be operated under field conditions 
and whether it would be possible to collect additional information on manure properties, 
the agricultural context and the receiving water bodies. 
In addition, it was attempted to question whether a (semi)quantitative relationship 
between the veterinary medicinal application and occurrence of the targeted compounds 
can be established. 
The third aspect of this first exploration was to lay down a basis for the development of 
an analytical approach for a multi-compound method possibly addressing also a non-
target approach. 
 
2.2 Sampling location 
2.2.1 Site characteristics and information 
The testing site chosen was suggested by the Agricultural University of Nitra (AUN), 
which maintains an extensive manure research facility aiming inter alia at reuse of 
processed manure for applications others than direct fertilisation. Thus, the University’s 
extensive research programs on the direct and indirect use of manure from different 
origin (cattle, pig, poultry and sheep) prior to or after digestion investigates to which 
extend the substrate can be used as growing media for algae aiming at fuel production.  
The field sites examined in this exploratory investigation are in the Danube River Basin in 
vicinity to the Nitra River, thus offering interesting macro-regional aspects (Fig. 6, Tab. 
6). The geographical position of Nitra (1h drive from Bratislava airport), facilitates 
dispatch operations. Furthermore, the test sites offer also access to groundwater wells 
and surface water bodies receiving agricultural runoff, thus allowing for a complete 
assessment on AMA/AMR/VMP propagation. 
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Figure 6 - Satellite map of Oponice settlement and sampling sites 
The University offers also know-how on farm management practises and on use of 
veterinary drugs, thus facilitating the interpretation of results. The activity was indeed 
embedded into running field experiments. Manure application takes place usually in 
autumn and the collection of runoff in that period is favoured by seasonal precipitations. 
A subsequent additional 3 sampling in spring can be performed to ensure a seasonal 
comparison. 
The Oponice site operated by the Slovak University of Agriculture has stock of approx. 
700 dairy cattles whose consumption of food and pharmaceuticals is closely monitored. It 
has a solid production of crops such as wheat, sugar beet, corn and Medicago L. and 
investigates also the reuse of manure, e.g. through biogasification. The site covers an 
area of more than 500 Ha and the manure produced from its own cattle stock is also 
used as fertilizers on their fields. Table 6 gives some more information on the agricultural 
parcels used in this investigation. 
 
Table 6 – Information about agricultural parcels used for sampling. For geographical 
position of the single parcels (Numbered 1 to 7) refer to Figure 6 
Parcel 
N° 
Name Crop Harvest 
yield 
Used 
fertilizer 
Amount of 
fertilizer 
used 
Date of 
application 
1 Pod hradskou Winter wheat 4.71 t/ha Liquid manure 
(Urine) 
30 m3/ha 12/08/2018 
Saltpetre 150 kg/ha 16/02/2017 
DASA 
(Ammonium 
nitrate + 
Ammonium 
sulphate) 
150 kg/ha 02/03/2017 
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Parcel 
N° 
Name Crop Harvest 
yield 
Used 
fertilizer 
Amount of 
fertilizer 
used 
Date of 
application 
2 Lúka Seed corn 5.4 t/ha Liquid manure 
(Urine) 
25 m3/ha 10/10/2016 
N-P-K 
(15:20:30) 
200 kg/ha 03/05/2017 
Saltpetre 150 kg/ha 23/05/2017 
3 Parcelová časť Seed corn 5.4 t/ha Manure 
(Cattle) 
30 t/ha 22/09/2016 
N-P-K 
(15:20:30) 
200 kg/ha 07/05/2017 
Saltpetre 150 kg/ha 23/05/2017 
4 Úzka Medicago L. 33.6 t/ha 
(green) 
Liquid manure 
(Urine) 
20 m3/ha 15/08/2016 
5 Pod hradom Winter wheat 6.5 t/ha Liquid manure 
(Urine) 
30 m3/ha 15/08/2016 
Saltpetre 150 kg/ha 17/02/2017 
DASA 
(Ammonium 
nitrate + 
Ammonium 
sulphate) 
150 kg/ha 02/03/2017 
NITROHUM 
(nitrogen 
content of 390 
kg/t of 
fertiliser) 
150 kg/ha 18/03/2016 
6 Nad hradskou Sugar beet Not 
available 
Manure 40 t/ha 01/09/2016 
Saltpetre 150 kg/ha 23/03/2017 
7 Za depom Winter wheat 
(seeded) 
Not 
available 
Liquid manure 
(urine) 
30 m3/ha 03/08/2017 
 
 
 
2.2.2 Impressions from the landscape 
The following photographs were taken in occasion of a preparatory excursion in Mar. 
2017 and document the rural characteristics of the side.  
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Figure 7 – Water storage tower at the site 
 
Water storage for farmland application. 
These water towers are typical for the 
area. Groundwater is pumped to the 
towers prior to use. Local water 
abstraction and consumption is 
documented and a tariff system for 
farmland use is in place. Access to this 
information is possible. 
Figure 8 – Landscape at the sampling site 
 
 
 
The landscape is mainly flat with slight 
hills and elevations. The entire area is 
characterised by land use mainly for 
feeding crop production. 
 
Figure 9 – Artificial lake at the Oponice site 
 
 
Artificial lakes like the ones shown are 
used for fish farming and exposed to 
run off. They interact also with natural 
buffer strips to regulate the water 
levels in the area and help to regulate 
nutrient loads. 
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Figure 10 – Drainage channel with water 
 
These channels are art of the typical 
drainage systems in the area by which 
water is drained on or in the soil to 
enhance agricultural production of 
crops. It may involve any combination 
of stormwater control, erosion control, 
and watertable control. 
Figure 11 –Larger drainage channel 
 
 
Larger drainage water agglomeration in 
vicinity to receiving water body 
connect the agricultural run-off with 
the local water bodies in the Nitra river 
basin. 
Figure 12 – Storage for processed manure 
 
 
Biogas production from manure is a 
common practice in the area. The 
digested manure, which is stored in 
such facilities, is used as fertilizer once 
the digestion process is terminated. It 
has a significantly higher solid content 
than untreated manure. If used 
undigested, the pig manure contains 
ca. 5% dry matter, thus being similar 
to sewage sludge. 
Both type of manure applications could 
be sampled in the study. 
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Figure 13 –Experimental bio-gasification plant 
 
 
Pig manure is mainly used first in bio-
gasification plants. The University 
research installation processes all pig 
manure from its research station. 
Figure 14 – Cow stables at the research facility 
 
 
Manure from cattle is used directly in 
the research plant. Here the stables of 
the University. The regions investigates 
also the further use of manure, e.g. as 
nutrient input to algae biofuel 
production thus increasing resource 
recovery. 
 
2.2.3 Supplementary information on veterinary drugs employed in the 
area 
The administration of veterinary medicinal products is highly regulated, in particular for 
livestock for food production. At the research station, the VMPs administered are 
documented in a logbook, which is updated continuously (Fig. 15).  
While there is not direct traceability of the APIs used and the occurrence of the 
compounds in the manure-exposed waters, the logbook entries deliver very pertinent and 
useful information in the development of an analytical method. 
The logbook in question documented date of application, the brand name of the product 
administered, reason for prescription, date and dose as well as the identification number 
of the animal receiving it and the signature of the authorized veterinarian. 
Based on this information, as list of active pharmaceutical ingredients, which are likely to 
be detected in the manure-exposed waters was compiled (Table 7). The list was 
subsequently completed with a series of (commercially) available standards for likely 
APIs and compounds (see next chapter). 
It is to be annotated that there is no direct traceability between the use of an API and its 
occurrence in the investigated samples. This applies also to the occurrence of non-
authorized substances. 
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Figure 15 - Extract of the logbook documenting application of VMPs at the research 
station 
 
Table 7 – List of likely active pharmaceutical ingredients (APIs) in the cattle manure and 
receiving waters 
Commercial 
name 
Structural formula Active ingredient 
Cepravin DC  
Cephalonium AB 
Fatroximin 
 
Rifaximin used as Anti-
inflammatories Anti-mastitic 
Antibiotic 
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Commercial 
name 
Structural formula Active ingredient 
Rilexine 200 
Cefalexin. 1st generation 
cephalosporin AB (The 
cephalosporins are a class of β-
lactam antibiotics) 
Duphamox:  
 
Amoxicillin trihydrate 
FATROXMIN 
foam:  
Rifaximin 
RISPOVAL IBR 
MARKER LIVE 
 
Vaccine against Infectious Bovine 
Rhinotracheitis  
BOVIGAL IBR  
Vaccine against Infectious Bovine 
Rhinotracheitis 
TETRA DELTA 
 
 
 
 
Active substances: 
• Neomycin (as Neomycin 
Sulphate) 
 
 
 
 
 
 
 
• Novobiocin (as 
Novobiocin Sodium)
 
 
 
 
• Dihydrostreptomycin (as 
Dihydrostreptomycin 
Sulphate)  
 
 
 
• Procaine Benzylpenicillin
 
 
 
 
 
 
 
 
 
 
• Prednisolone 
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Commercial 
name 
Structural formula Active ingredient 
NAXCEL HD  
Safe and effective antibiotic 
against bacterial Pneumonia 
ACEGON 
Gonadorelin (as acetate) per 
animal 
DUPHALYTE 
 
 
 
 
 
 
 
 
Active Ingredients: 
• Dexpanthenol 
 
 
 
• Nicotinamide 
 
 
 
 
 
• Pyridoxine Hydrochloride
 
 
 
 
 
 
• Riboflavin 
 
 
 
 
 
• Sodium Phosphate, 
Thiamine Hydrochloride 
DOXYGAL PLV 
 
Doxycyclini hyclas 50.0 mg. 
Doxycycline hyclate is a broad-
spectrum antibiotic synthetically 
derived from oxytetracycline. 
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Commercial 
name 
Structural formula Active ingredient 
BETAMOX LA  
Amoxicillin  
 
2.1 Sampling 
The exploratory sampling was carried out in November 8 to 10, 2017 in the Oponice 
/Nitra area. Sampling was conducted jointly by JRC Staff (H. Skejø, G. Mariani) and AUN 
Staff (N. Głowacka, J. Gaduš). Impressions from the sampling activities are shown in 
Figures 16 to 19. Weather conditions for the day of sampling were as follows: 
 
Table 8 - Weather conditions on day of sampling7 
Temperature Parametric value  
Mean Temperature 8 °C 
Max Temperature 9 °C 
Min Temperature 7 °C 
Degree Days   
Heating Degree Days 18 
Moisture   
Dew Point 6 °C 
Average Humidity 84 
Maximum Humidity 89 
Minimum Humidity 77 
Precipitation   
Precipitation 0.0 mm 
Sea Level Pressure   
Sea Level Pressure 1 022.38 hPa 
Wind   
Wind Speed 4 km/h 
Max Wind Speed 14 km/h 
Max Gust Speed MM 
Visibility 4.0 kilometers 
Events  None 
 
                                          
7 Source: Averaged Metar Reports. 
https://www.wunderground.com/history/wmo/11855/2017/11/9/DailyHistory.html?req_city=Nitra&req_sta
te=NI&req_statename=Slovakia&reqdb.zip=00000&reqdb.magic=1&reqdb.wmo=11855 (last accessed 
04/01/2018) 
 31 
  
Figure 16 – Manure deposit at the Oponice 
Plant 
 
Along with a nutrient management 
plan, many farmers use manure 
storage structures and barnyard runoff 
controls to improve manure 
management and protect water 
quality. Storage allows manure to be 
safely stockpiled until conditions are 
environmentally safe for spreading. 
 
 
Figure 17 – Sampling of surface water samples 
adjacent to field site 
 
 
Water that does not soak into the 
ground, whether from rain, snowmelt, 
a hose, or leaking pipes, is called 
runoff. Runoff picks up contaminants, 
such as nutrients, pathogens, and 
bacteria from manure and can 
transport them to the nearest water 
resource (lake, pond, wetland, stream, 
or river). 
 
 
 
 
Figure 18 – Sampling at groundwater well 
 
 
Manure runoff from cropland and 
pastures or discharging animal feeding 
operations and concentrated animal 
feeding operations not only reaches 
surface water bodies but often also 
groundwater.  
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Figure 19 – Soil sampling 
 
Manure has value. That value may 
result from improvements in soil 
quality, increases in yield, and 
replacement of commercial nutrient 
required for crop production. 
Therefore the use of organic manure is 
one of the alternative ways for 
enhancing production and improves the 
soil health. 
 
 
2.2 Samples registry 
In total 12 water samples from field run-off/drainage channels and from ground water 
wells (7 filter samples [run through approx. 1 l]) were taken using the in-house 
developed Mariani Box. In addition 5 large scale samples for exploratory investigations of 
AMR were taken. The sample set was completed by 4 soil samples from the test fields as 
well as 2 solid and 1 liquid manure samples. A five replicate sample from the digestion 
plant was taken prior to the campaign. 
 
 
Table 9 –List of samples taken during the campaign 
Sample name Sampling date Sample type 
Nitra - Oponice Farm, Field no7, location A O9/11/2017 Water (MB Filter) 
Nitra - Oponice Farm, Field no7, location B O9/11/2017 Water (MB Filter) 
Nitra - Oponice Farm, Ground Water from Well Field 2 
location C 
O9/11/2017 Water (MB Filter) 
Nitra - Oponice Farm, Run off water from field 2&3 
location D 
O9/11/2017 Water (MB Filter) 
Nitra - Oponice Farm, Stream Oponice location E , 50 m 
from Nitra River 
O9/11/2017 Water (MB Filter) 
Nitra - Oponice Farm, Stream Oponice location F , 25 m 
from Nitra River 
O9/11/2017 Water (MB Filter) 
Nitra - Oponice Farm, Nitra River near pumphouse , 
location G 
O9/11/2017 Water (MB Filter) 
Nitra - Oponice Farm, Nitra River near pumphouse , 
location G 
O9/11/2017 Water (MB Filter) 
Nitra - Oponice Farm, Field no7, location B O9/11/2017 Large volume for 
AMR tests 5L 
Nitra - Oponice Farm, Ground Water from Well Field 2 
location C 
O9/11/2017 Large volume for 
AMR tests 5L 
Nitra - Oponice Farm, Run off water from field 2 & 3 
location D 
O9/11/2017 Large volume for 
AMR tests 5L 
Nitra - Oponice Farm, Stream Oponice location E, 50 m 
from Nitra River 
O9/11/2017 Large volume for 
AMR tests 5L 
Nitra - Oponice Farm, soil sample Field 1 O9/11/2017 Soil (plastic bag) 
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Sample name Sampling date Sample type 
Nitra - Oponice Farm, soil sample Field 2 O9/11/2017 Soil (plastic bag) 
Nitra - Oponice Farm, soil sample Field 3 O9/11/2017 Soil (plastic bag) 
Nitra - Oponice Farm, soil sample Field 7 O9/11/2017 Soil (plastic bag) 
Nitra - Oponice Farm, solid cattle manure 1 O9/11/2017 Manure (plastic bag) 
Nitra - Oponice Farm, solid cattle manure 2 O9/11/2017 Manure (plastic bag) 
Nitra - Oponice Farm, liquid cattle manure O9/11/2017 liquid manure (glass 
bottle) 
Nitra - Oponice Farm, digested pig manure September 2017 Digested manure 
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3 Towards a multi-compound analytical methodology 
While the experiences gained during the exploratory sampling are useful to set-up a 
sampling protocol for an EU-wide approach, the samples obtained are key elements in 
the development of an appropriate and versatile multi-compound analytical methodology. 
The development of such a method is obviously challenging and needs to consider a 
series of limiting boundary conditions, such as: 
1. The variety of chemical compounds to be addressed: as shown in the previous 
chapters, it is difficult to fully anticipate all occurring active pharmaceutical 
ingredients occurring in (processed) manure and subsequently in fields and waters 
exposed to it. In addition, modern animal husbandry uses also a series of 
pesticides for sanitation and precaution purposes. Many of these compounds are 
relevant, too, and need to be considered from an eco-toxicological perspective. 
2. The fundamentally different properties of the sample matrices: manure and 
processed manure may vary significantly in their matrix properties, which in 
return influence the extraction behaviour of the analytical compounds of interest. 
The same applies to the soil properties or water quality. 
3. The broad range of concentrations: in general the closer the matrix, from which a 
sample is obtained, to the animal, the higher the concentration of the compounds 
of interest will be. Thus, we can expect concentrations that are orders of 
magnitude higher in unprocessed or poorly processed manure compared to for 
instance surface or groundwater samples. 
4. The limited resources available: the most time consuming step in trace organic 
analyses is the final evaluation of the acquired spectra. In addition the amount of 
compounds to be addressed is very large. To cope with this analytical challenge a 
so-called non-targeted approach which will lead to a "digital freezing" of the 
chemical information in the samples will be used in conjunction with a targeted 
analyses of likely compounds of interest. 
5. The logistic and organisational challenges: a high degree of logistical coordination 
is needed to ensure that data are reproducible and quality documented with an 
appropriate level of accuracy and precision. 
 
Considering these restraints it was decided to aim the development of a combined 
methodology using both, a targeted and non-targeted approach, which will be refined in 
the forthcoming steps.  
 
3.1 Preliminary compound selection and initial choice 
Table 10 reports the compounds considered initially in the present study.  Some of them 
were indicated as “priority veterinary medicine active ingredients recommended for 
further study to assess toxicological risks resulting from human exposure pathways” 
(Boxall, 2012). Others relate more to the classical context of EU legislation and soil 
management aspects. 
Starting from this first set of substances, a sketch for an appropriate sampling 
preparation protocol and subsequent analyses using an LC-MS/MS approach was 
developed. 
The technique used was already tested successfully in similar occasions, e.g. in the 
analyses of effluents from waste water treatment plants (Loos et al., 2012; Jarosova et 
al., 2014), the stability assessment of compounds of emerging concern in environmental 
water samples (Mariani et al., 2017) and the investigation of illicit drug residues and 
other polar compounds in reclaimed waters used in water reuse applications (Tavazzi et 
al., 2017). 
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Table 10 – Initial selection of study compounds to start the analytical method 
development for a multi-matrix method combining a targeted and non-targeted 
analytical approach 
Analyte Comment  
Heavy metals* (Cadmium, Copper Nickel, 
Lead, Zinc, Mercury, Chromium  
Council Directive 86/278/EEC of 12 June 1986 
on the protection of the environment, and in 
particular of the soil, when sewage sludge is 
used in agriculture Nitrogen* 
Phosphorous* 
Potassium* 
Dry matter* 
Ketoconazole Imidazole antifungal drugs 
Miconazole 
Fluconazole 
Climbazol  
Levamisole hydrochloride Imidazothiazole anthelmintic 
Oxolinic acid Quinolone antimicrobial agent 
Sulfadiazin  Sulfonamide antimicrobial agent 
Toltrazuril Triazinetrione derivative; anti protozoal agent  
Diazinon Organothiophosphate insecticide 
Florfenicol Broad-spectrum, primarily bacteriostatic, 
antibiotic  
Bronopol  Antimicrobial agent  
Albendazole Benzimidazole anti protozoal agent  
Monensin sodium Polyether antimicrobial agent 
Sarafloxacin  Quinolone antimicrobial agent 
Ofloxacin second-generation fluoroquinolone 
Enrofloxacin Fluoroquinolone antimicrobial agent 
Marbofloxacin 
Oxytetracycline Tetracycline antibiotic, 
Chlorotetracycline 
Amoxicillin β-lactam antimicrobial agent 
Sulfadimethoxine Sulfonamide antimicrobial agent 
Sulfathiazole 
Sulfamethoxazole 
Sulfamethazine 
Roxithromycin Macrolides antimicrobial agent 
Erythromycin 
Clarythromycin 
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3.2 Sample preparation 
To initiate the development of the analytical procedure it was decided to perform the 
tests on non-processed (i.e.: cattle urine) and processed manure (i.e.: digestate) (Table 
9). 
 
3.2.1 Non-processed manure (cattle urine) 
Cattle urine sample was allowed to equilibrate at room temperature, then vigorously 
hand-shaken and a 0.5 ml aliquot transferred into a 1.5 ml Eppendorf PP vial. The 
opportune amount of internal standard mixture was added and the sample was vortex 
mixed for 30 seconds.  
An aliquot of 0.5 ml of acetonitrile was then added for protein precipitation.  
The mixture was vortex mixed again for 30 seconds and then centrifuged at 10 000 rpm 
for 10 minutes.  
An aliquot of 100 µl of the supernatant was finally transferred to an auto-sampler vial for 
LC-MS analysis. 
 
3.2.2 Processed manure  
For chromatographic purposes, a digestate sample was filtered through 5um and 1 µm 
glass fibre disks, consecutively.  
10 ml filtered aliquot was then withdrawn and diluted with 90 ml of MilliQ water to obtain 
a final volume of 100 ml. A Polypropylene bottle was used as sample container. 
The opportune amount of Internal Standard mixture was added and the sample was then 
extracted using OASIS HLB cartridges according to the procedure reported In Table 11.  
 
Table 11 - Solid-phase extraction protocol applied 
SPE Step Solvent  Volume (ml) Flow (ml/min) 
Conditioning  Ethyl acetate  5 15 
Methanol 5 15 
Water 5 15 
Loading  100 ml 5 
Wash  10% methanol 5  
Drying for 30 minutes under nitrogen flow 
Elution Ethyl acetate  6 2 
Methanol 6 2 
The ethyl acetate fraction was evaporated to dryness under nitrogen, reconstituted to 1 
ml with reconstitution solution and analysed.  
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The methanolic fraction was reduced under nitrogen to 100 µl volume, transferred into 
an autosampler vial and analysed. 
 
3.3 Instrumental methods 
3.3.1 LC-MS/MS method  
3.3.1.1 UHPLC conditions  
The experimental conditions for polar compounds UHPLC-MSMS analysis are reported In 
Table 12. 
 
Table 12 - UHPLC experimental conditions  
Parameter Type/Values 
Pumps: Binary Solvent Manager, Model UPB, Waters (Milford, MA, USA). 
Autosampler: Sample Manager, Model UPA, Waters (Milford, MA, USA). 
Detector: QTRAP 5500, Applied Biosystems MDS SCIEX, (Foster City, CA, U.S.A) 
equipped with Turbo V™ ion source. 
Flow rate: 0.5 ml/min 
Injection volume: 10 µ 
Analytical column: CSH C18 (Thermo), 2.1 x 100 mm, 1.7 µm 
Mobile phase: A: 0.1% HCOOH; B: MeOH:AcN 50/50, % v/v 
Reconstituting 
solution 
0.1% HCOOH: MeOH:AcN 95:2.5:2.5, % v/v 
 
The chromatography was performed in gradient mode according to the scheme reported 
in the Table 13. 
 
Table 13 - UHPLC gradient scheme 
Time (min) Mobile phase (A%) Mobile Phase B (%) 
0 95 5 
1 95 5 
5 5 95 
6 5 95 
6.1 95 5 
8 95 5 
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3.3.1.2 QTRAP 5500 MS/MS operative conditions  
An ABSciex QTRAP5500 mass spectrometer equipped with Turbo V™ ion source was used 
for polar compounds analysis. The instrument was previously tuned and calibrated in 
electrospray mode using PPG's. Prior to analysis all the specific parameters were 
optimized infusing a 1 µg/mL standard solution of analytes and I.S.s.  
The eluate from the column was introduced directly into the ion source. The rapid 
desolvatation and vaporization of the droplets minimizes thermal decomposition and 
preserves their molecular identity.  
The data were collected using the software program Analyst 1.6.2 
All calculations were based on chromatographic peak area ratios for the MRM precursor-
product ion transitions for analytes versus I.S.s. 
 
 
Table 14 - General operating conditions for QTRAP 5500 MS/MS 
Parameter Value
Scan Type: Scheduled MRM 
Polarity: Polarity Switching: Positive/Negative 
Ion Source: Turbo Spray
Resolution Q1: Unit
Resolution Q3: Unit
MR Pause: 5.0000 msec
Curtain gas (CUR):  25.00
Collision Gas (CAD):  Medium
Temperature (TEM):  550.00
IonSpray Voltage (IS):  ± 4500.00
Ion Source Gas 1 (GS1) 55
Ion Source Gas 2 (GS2) 45
Target Scan Time  0.1 sec
MRM detection window  80 sec
 
 
MS/MS parameters of the multi-compound method are reported in Table 15.  It is to be 
annotated that this table includes also other analytes than the ones reported in Table 10. 
The enlarged compound list considers specific target compounds for the antimicrobial 
agents monitoring. This gives the possibility of a wider characterisation of collected 
samples, in case of positive findings.  
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Table 15 - MS-MS parameters 
Q1 
(Mass) 
Q3 
(Mass) 
Time 
(min) 
ID DP 
(Volts) 
EP 
(Volts) 
CE 
(Volts) 
255 197 4.35 2,4,5-T  -70 -10 -22
255 161 4.35 2,4,5-T 1 -70 -10 -41
219 161 4.07 2,4-D -130 -10 -24
219 125 4.07 2,4-D 1 -130 -10 -38
225 167 4.07 2,4-D 13C6 -68 -10 -19
162 78 2.75 Acesulfame K -120 -10 -46
162 82 2.75 Acesulfame K -120 -10 -27
166 86 2.75 Acesulfame K-D4 -151 -10 -20
166 78 2.75 Acesulfame K-D4 -151 -10 -42
360 274 4.13 Bezafibrate  -100 -10 -24
360 154 4.13 Bezafibrate  -100 -10 -39
364 278 4.13 Bezafibrate D4 -165 -10 -24
294 250 4.51 Diclofenac -42 -10 -16
294 214 4.51 Diclofenac -42 -10 -29
300 256 4.51 Diclofenac 13C6 -173 -10 -15
269 145 0 E1 -100 -10 -53
269 143 0 E1 1  -100 -10 -74
272 146 0 E1 13C3 -150 -10 -88
272 148 0 E1 13C3 1 -150 -10 -50
271 145 0 E2 -83 -10 -60
271 143 0 E2 1  -83 -10 -78
275 147 0 E2 d4 -100 -10 -55
275 187 0 E2 d4 1  -100 -10 -50
295 145 0 EE2 -100 -10 -70
295 143 0 EE2 1 -100 -10 -50
299 145 0 EE2 D4 -100 -10 -60
299 187 0 EE2 d4 1 -100 -10 -45
249 121 4.74 Gemfibrozil -100 -10 -30
249 106 4.74 Gemfibrozil -100 -10 -60
255 121 4.74 Gemfibrozil d6 -100 -10 -20
205 161 0 Ibuprofen -132 -10 -10
205 159 0 Ibuprofen -132 -10 -10
208 163 0 Iburpofen 13C3 -81 -10 -11
199 141 3.97 MCPA -147 -10 -21
199 105 3.97 MCPA -147 -10 -40
229 169 3.97 Naproxen  -100 -10 -47
229 185 3.97 Naproxen  -100 -10 -10
233 169 3.97 Naproxen 13C3 -42 -10 -46
395 359 2.44 Sucralose -145 -10 -17
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Q1 
(Mass) 
Q3 
(Mass) 
Time 
(min) 
ID DP 
(Volts) 
EP 
(Volts) 
CE 
(Volts) 
397 361 2.44 Sucralose 1  -145 -10 -17
395 35 2.44 Sucralose 2 -145 -10 -16
401 365 2.44 Sucralose d6 -160 -10 -16
294.1 198.1 2.98 N-Acetyl-SMZ -100 -10 -24
294.1 133.8 2.98 N-Acetyl-SMZ -100 -10 -31
265.3 35 0 Pentachlorophenol -120 -10 -96
265.3 80 0 Pentachlorophenol 1  -120 -10 -31
640.8 78.9 0 HBCD -260 -10 -93
640.8 81.1 0 HBCD 1 -260 -10 -66
213 141 4.21 Mecoprop -100 -10 -30
213 71 4.21 Mecoprop 1  -100 -10 -15
271 207 0 Pentachlorophenol 13C6  -180 -10 -50
271 236 0 Pentachlorophenol 13C6 1  -180 -10 -40
213 169 4.05 PFBA -96 -10 -13
217 172 4.05 PFBA 13C4 -99 -10 -13
299 80 4.81 PFBS -260 -10 -66
299 99 4.81 PFBS -260 -10 -39
313 269 5.06 PFHxA -107 -10 -12
313 119 5.06 PFHxA -107 -10 -28
315 270 5.06 PFHxA 13C2 -60 -10 -13
399 80 0 PFHxS -260 -10 -93
399 99 0 PFHxS -260 -10 -66
363 319 5.5 PFHpA -116 -10 -14
363 169 5.5 PFHpA -116 -10 -24
413 369 5.86 PFOA -122 -10 -16
413 169 5.86 PFOA -122 -10 -26
417 372 5.86 PFOA 13C4 -119 -10 -15
499 80 6.11 PFOS -260 -10 -97
499 99 6.11 PFOS -260 -10 -83
503 80 6.11 PFOS 13C4 -276 -10 -104
463 419 6.17 PFNA -122 -10 -19
463 219 6.17 PFNA -122 -10 -25
463 169 6.17 PFNA -122 -10 -27
468 423 6.17 PFNA 13C5 -57 -10 -16
202 144 3.97 MCPA D3 -100 -10 -30
202 108 3.97 MCPA D3 1  -100 -10 -45
648.9 78.9 0 HBCD lab -80 -10 -30
211 139 0 4-t-OP 13C6 -80 -10 -30
211 123 0 4-t-OP 13C61 -250 -10 -5
424 424 4.59 Toltrazuril -100 -10 -5
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Q1 
(Mass) 
Q3 
(Mass) 
Time 
(min) 
ID DP 
(Volts) 
EP 
(Volts) 
CE 
(Volts) 
356 185 2.75 Florfenicol -120 -10 -30
356 336 2.75 Florfenicol 1 -120 -10 -13
199 155 4.18 Bronopol -100 -10 -20
199 181 4.18 Bronopol 1  -100 -10 -15
199 80 4.18 Bronopol 2  -100 -10 -50
427.2 427.2 4.59 Toltrazuril D3 -100 -10 -10
271 180 2.85 10,11-dihydro-10,11-dihydroxy-
carbamazepine 
80 10 47
271 210 2.85 10,11-dihydro-10,11-dihydroxy-
carbamazepine 1 
80 10 19
271 253 2.85 10,11-dihydro-10,11-dihydroxy-
carbamazepine 2 
80 10 10
223 126 2.85 Acetamiprid 80 10 29
223 73 2.85 Acetamiprid 1 80 10 76
225 128 2.85 Acetamiprid 2 80 10 29
225 75 2.85 Acetamiprid 3 80 10 74
226 126 2.85 Acetamiprid-d3 80 10 27
226 73 2.85 Acetamiprid-d3 1 80 10 80
226 190 2.85 Acetamiprid-d3 2 80 10 19
270 238 4.34 Alachlor 120 10 16
270 162 4.34 Alachlor 120 10 28
216 174 3.62 Atrazine 258 10 25
216 104 3.62 Atrazine 258 10 40
219 177 3.62 Atrazine 13C3 100 10 25
749.6 591.4 0 Azythromycin 200 10 40
749.6 573.3 0 Azythromycin 1 200 10 47
120 65 2.24 Benzotriazole 209 10 29
120 92 2.24 Benzotriazole 1  209 10 24
124 69 2.24 Benzotriazole d4 56 10 35
237 194 3.54 Carbamazepine 250 10 28
237 165 3.54 Carbamazepine 250 10 60
247 204 3.54 Carbamazepine d10 234 10 31
222 77 2.7 Chloridazon  204 10 52
222 65 2.7 Chloridazon 1 204 10 53
222 92 2.7 Chloridazon 2 204 10 34
748.5 590.5 3.31 Clarythromycin 100 10 28
748.5 558.5 3.31 Clarythromycin 1 100 10 31
250 132 2.62 Clothianidin 50 10 26
250 169 2.62 Clothianidin 1 50 10 16
252 134 2.62 Clothianidin 2 50 10 24
253 172 2.62 Clothianidin-d3 1 50 10 18
253 132 2.62 Clothianidin-d3 1 50 10 23
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Q1 
(Mass) 
Q3 
(Mass) 
Time 
(min) 
ID DP 
(Volts) 
EP 
(Volts) 
CE 
(Volts) 
254 198 3.77 Cybutrine 1 261 10 26
263 74 3.77 Cybutrine d9 1  269 10 61
254 74 3.77 Cybutryne 2 261 10 30
263 199 3.77 Cybutryune d9 269 10 27
233 72 3.78 Diuron 169 10 25
233 133 3.78 Diuron 1 169 10 53
240 78 3.78 Diuron-d6 156 10 24
240 135 3.78 Diuron-d6 156 10 57
240 161 3.78 Diuron-d6 156 10 39
734.5 576 2.99 Erythromycin 80 10 26
734.5 558 2.99 Erythromycin 1 80 10 25
736 578 2.99 Erythromycin 13C2 130 10 26
736 560 2.99 Erythromycin 13C2 1 130 10 26
736 160 2.99 Erythromycin 13C2 2 160 10 36
734.5 83 2.99 Erythromycin 2 80 10 95
734.5 158.2 2.99 Erythromycin 3 80 10 40
256 209 2.7 Imidacloprid 60 10 21
256 175 2.7 Imidacloprid 1 60 10 27
260 213 2.7 Imidacloprid-d4 60 10 26
260 179 2.7 Imidacloprid-d4 1 60 10 29
207 72 3.73 Isoproturon 230 10 25
207 165 3.73 Isoproturon 230 10 20
210 75 3.73 Isoproturon-D3 199 10 25
210 168 3.73 Isoproturon-D3 199 10 21
226 169 4.05 Methiocarb 30 10 12
226 121 4.05 Methiocarb 1 30 10 25
229 169 4.05 Methiocarb d3 110 10 71
229 121 4.05 Methiocarb d3 1  110 10 76
284 252 4.38 Metolachlor 200 10 22
284 176 4.38 Metolachlor 200 10 35
290 258 4.38 Metolachlor d6 196 10 20
268 91 0 Metopropol 261 10 68
268 103 0 Metopropol 261 10 57
275 122 0 Metopropol d7 1  274 10 26
345 220 5 Oxadiazon 90 10 28
345 303 5 Oxadiazon 1 90 10 21
202 104 3.23 Simazine 253 10 34
202 132 3.23 Simazine 1 253 10 26
205 70 3.3 Simazine 13C3 218 10 45
205 106 3.3 Simazine 13C3 1  218 10 35
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Q1 
(Mass) 
Q3 
(Mass) 
Time 
(min) 
ID DP 
(Volts) 
EP 
(Volts) 
CE 
(Volts) 
279 92 2.35 Sulfamethazine 232 10 41
279 124 2.35 Sulfamethazine 1 232 10 32
285 70 2.35 Sulfamethazine 13C6 165 10 70
254 156 2.7 Sulfamethoxazole 150 10 22
254 92 2.7 Sulfamethoxazole 150 10 38
260 98 2.7 Sulfamethoxazole 13C6 70 10 36
242 186 3.54 Terbutryn 255 10 25
242 91 3.54 Terbutryn 255 10 36
247 191 3.54 Terbutryn d5 228 10 27
247 91 3.54 Terbutryn d5 1 228 10 36
230 174 0 Terbutylazine 219 10 26
230 132 0 Terbutylazine 219 10 35
253 126 3.08 Thiacloprid 100 10 27
253 90 3.08 Thiacloprid 1 100 10 55
255 128 3.08 Thiacloprid 2 77 10 28
255 90 3.08 Thiacloprid 3 77 10 53
257 126 3.08 Thiacloprid-d4 100 10 28
257 73 3.08 Thiacloprid-d4 1 100 10 83
257 90 3.08 Thiacloprid-d4 2 100 10 54
292 132 0 Thiamethoxam 60 10 35
292 211 0 Thiamethoxam 1 60 10 18
295 214 0 Thiamethoxam-d3 70 10 19
295 132 0 Thiamethoxam-d3 1 70 10 30
291 123 1.48 Trimethoprim 293 10 34
291 230 1.48 Trimethoprim 1  293 10 33
294 126 1.48 Trimethoprim 13C3 221 10 33
294 233 1.48 Trimethoprim 13C3 1 221 10 32
265.3 248 4.45 Aclonifen 120 10 21
265.3 194.1 4.45 Aclonifen 1  120 10 25
343 311 0 Bifenox 40 10 13
172.3 137.2 0.64 Gabapentin 60 10 21
172.3 154.2 0.64 Gabapentin 1  60 10 16
189.3 56 2.47 Phenazone  120 10 45
189.3 77 2.47 Phenazone 1  120 10 51
309.3 273.3 5 Quinoxyfen 100 10 38
309.3 197 5 Quinoxyfen 1  100 10 44
359 99 4.53 Chlorfenvinphos 100 10 46
359 170 4.53 Chlorfenvinphos 1  100 10 55
350.6 96.8 0 Clorpyrifos 80 10 45
350.6 197.8 0 Chlorpyrifos 1  80 10 29
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Q1 
(Mass) 
Q3 
(Mass) 
Time 
(min) 
ID DP 
(Volts) 
EP 
(Volts) 
CE 
(Volts) 
221.9 109 3.24 Dichlorvos 100 10 25
221.9 95 3.24 Dichlorvos 1  100 10 50
269.8 253 4.45 Aclonifen D5 120 10 22
269.8 186 4.45 Aclonifen D5 1  120 10 40
283.2 251.1 4.34 Alachlor D13 120 10 15
283.2 175.3 4.34 Alachlor D13 1  120 10 26
346.3 314 0 Bifenox D3 80 10 12
369 205 4.53 Chlorfenvinphos D10 100 10 30
369 133 4.53 Chlorfenvinphos D10 1 100 10 25
360.1 199 0 Chlorpyrifos D10 100 10 29
360.1 107 0 Chlorpyrifos D10 1  100 10 80
227 115 3.24 Dichlorvos D6 100 10 26
227 83 3.24 Dichlorvos D6 1  100 10 37
313 276.2 5 Quinoxyfen D4 80 10 35
313 163.2 5 Quinoxyfen D4 1  80 10 60
222 204 2.85 Quinmerac  50 10 23
222 140 2.85 Quinmerac 1  50 10 50
198 140 0 Caffeine 13C3 150 10 27
198 112 0 Caffeine 13C31 150 10 33
192 91 0 DEET 244 10 41
192 119 0 DEET 244 10 24
198 91 0 DEET d6 80 10 42
134 77 0 5-methyl-1H-benzotriazole 260 10 34
134 106 0 5-methyl-1H-benzotriazole 1 260 10 23
332 231 0 Ciprofloxacin 290 10 37
332 314 0 Ciprofloxacin 290 10 25
336 235 0 Ciprofloxacin 13C3 239 10 51
336 291 0 Ciprofloxacin 13C3 1  239 10 25
362 261 2.01 Ofloxacin 120 10 39
362 318 2.01 Ofloxacin 120 10 27
461 444 0 Oxytetracyclin 120 10 80
461 426.3 0 Oxytetracyclin 80 10 25
461 201.1 0 Oxytetracyclin 1  80 10 51
461 127.2 0 Oxytetracyclin 2 80 10 104
479.2 444 2.14 Chlorotetracyclin 80 10 23
479.2 462.3 2.14 Chlorotetracyclin 1 80 10 23
479.2 139 2.14 Chlorotetracyclin 2 80 10 137
305 159 4.53 Diazinon 100 10 30
305 97 4.53 Diazinon 1  100 10 55
251 156 1.56 Sulfadiazine 60 10 19
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Q1 
(Mass) 
Q3 
(Mass) 
Time 
(min) 
ID DP 
(Volts) 
EP 
(Volts) 
CE 
(Volts) 
251 99 1.56 Sulfadiazine 1  60 10 27
251 108 1.56 Sulfadiazine 2  60 10 34
531.3 81 3.21 Ketoconazole 120 10 144
531.3 489.3 3.21 Ketoconazole 1  120 10 50
417.2 159 3.77 Miconazole  160 10 40
417.2 161 3.77 Miconazole 1  160 10 43
417.2 89 3.77 Miconazole 2  160 10 116
307.3 238.2 2.62 Fluconazole  70 10 24
307.3 220.3 2.62 Fluconazole 2  70 10 28
293 69 3.2 Climbazole  90 10 27
293 99 3.2 Climbazole 2  90 10 63
205.2 89 0.56 Levamisole 100 10 85
205.2 178 0.56 Levamisole 1  100 10 30
262.3 244.1 3.09 Oxolinic acid  90 10 28
262.3 216.3 3.09 Oxolinic acid 1  100 10 39
266.3 234.3 3.31 Albendazole 120 10 30
266.3 191 3.31 Albendazole 1 120 10 46
266.3 159 3.31 Albendazole 2 120 10 55
693.4 479 5.52 Monensin 100 10 70
693.4 461 5.52 Monensin 1 100 10 70
693.4 675.6 5.52 Monensin 2 100 10 5
269.3 234.2 3.31 Albendazole D3 100 10 27
269.3 191.2 3.31 Albendazole D3 1 100 10 45
269.3 159.3 3.31 Albendazole D3 2 100 10 51
267.2 249.3 3.09 Oxolinic acid D5 50 10 30
267.2 161 3.09 Oxolinic acid D5 1 50 10 47
297 201.2 3.2 Climbazole D4 80 10 42
297 102.8 3.2 Climbazole D4 1 80 10 64
535.3 493 3.21 Ketoconazole D4 100 10 45
535.3 81 3.21 Ketoconazole D4 1 100 10 120
311 242.3 2.62 Fluconazole D4 60 10 25
315.3 170 4.53 Diazinon D10 70 10 35
315.3 154.2 4.53 Diazinon D10 1 100 10 5
386.1 368.3 2.25 Sarafloxacin 120 10 33
386.1 299.1 2.25 Sarafloxacin 1 120 10 37
386.1 342.1 2.25 Sarafloxacin 2  120 10 28
360.3 316.3 2.17 Enrofloxacin 120 10 25
360.3 342.3 2.17 Enrofloxacin 1 120 10 31
360.3 245.1 2.17 Enrofloxacin 2 120 10 38
363.2 72.1 1.88 Marbofloxacin  90 10 26
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Q1 
(Mass) 
Q3 
(Mass) 
Time 
(min) 
ID DP 
(Volts) 
EP 
(Volts) 
CE 
(Volts) 
363.2 319.8 1.88 Marbofloxacin 1 90 10 22
363.2 345.3 1.88 Marbofloxacin 2 90 10 26
366.3 349.3 0 Amoxicillin  70 10 10
366.3 113.8 0 Amoxicillin 1 70 10 30
366.3 134.2 0 Amoxicillin 2 70 10 45
838 116.3 3.26 Roxitrhomycin  70 10 80
838 158.4 3.26 Roxithromycin 1 70 10 41
838 679.33 3.26 Roxithromycin 2 70 10 30
582.3 236.3 0 Streptomycin 30 10 40
582.3 246.2 0 Streptomycin 1 30 10 48
582.3 540.4 0 Streptomycin 2 30 10 38
311.3 156.2 3.08 Sulfadimethoxine 80 10 25
311.3 92 3.08 Sulfadimethoxine 1 80 10 45
311.3 108 3.08 Sulfadimethoxine 2 80 10 40
311.3 245 3.08 Sulfadimethoxine 3 80 10 25
256 92 1.93 Sulfathiazole 60 10 40
256 108.2 1.93 Sulfathiazole 1 60 10 40
256 156 1.93 Sulfathiazoel 2 60 10 24
325.2 264.9 0 Norfloxacin D5 80 10 10
325.2 233.2 0 Norfloxacin D5 1 80 10 40
325.2 307.1 0 Norfloxacin D5 2 80 10 30
 Q1: Parent ion [m/z]+; Q3: Product ion [m/z]+; RT: retention time (min); ID: analyte name; DP: Declustering Potential; EP: Entrance 
Potential; CE: Collision Energy; CXP: Collision Cell Entrance Potential.   
 
3.3.2 Inorganic analytical determinations 
In order to better characterise the digestate samples as well as to assess the possibility 
to outsource routine analytical determinations, two digestate samples were sent to a 
commercial laboratory that operate its methods under ISO 9001 and ISO 17025, the 
latter only for certain measurements. Table 16 lists the methods and measurement 
principles used by the sub-contracted laboratory. The identity of the laboratory is not 
revealed in this report for data protection reasons. Table 16 also indicates the list of 
equivalent CEN methods where available, however the methods are operated under 
Italian national regulation. For each test, 500 ml of aliquots where used. 
 
Table 16 – Test standards used by commercial laboratory characterising the digestate 
samples 
Parameter Test method 
used 
Test principle and summary 
Dry matter 
content at 
105°C 
CNR IRSA 2 Q 64 
Vol 2 1984  
After filtration at 0.45 um samples are dried to constant mass in an oven 
at 105 °C until a constant weigh is reached. 
The method is equivalent to CEN EN 14346 (2006) 
Loss on 
ignition 
600°C 
CNR IRSA 2 Q 64 
Vol 2 1984  
A dried test sample is heated in a furnace to constant mass at 600°C. 
The difference in mass before and after the ignition process is used to 
calculate the loss of ignition. The determination is performed on a dried 
sample or directly on the un-dried sample including a drying step or by 
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Parameter Test method 
used 
Test principle and summary 
referring to dry matter. 
The method is equivalent to CEN EN 15169 (2007) 
Total organic 
carbon 
DM 13/09/1999 
GU 248 
21/10/1999 Met. 
VII.2 
Under standard conditions, organic carbon is oxidized to carbon dioxide, 
using potassium dichromate solution in presence of sulphuric acid. 
Excess of potassium dichromate is then titrated with an iron (II) sulfate 
solution. Complete titration is appreciated by adding a proper redox 
indicator or by potentiometry, using a platinum electrode. Heating the 
mixture at 160°C ensures the reaction between organic carbon and 
dichromate being quantitative. 
No equivalent EU Standard 
Cr VI APAT CNR IRSA 
3010A Man. 
29:2003 
Chromate is extracted from the sample with water at room temperature. 
The chromate concentration in the extract is measured by colorimetry 
with a spectrophotometer using 1,5-diphenylcarbazide. 
When chromate reduces the 1,5-diphenylcarbazide a magenta coloured 
complex of 1,5-diphenylcarbazone and chromium is formed which can be 
measured colorimetrically at 540 nm. The method is equivalent to CEN 
EN 16318 (2016) 
Cd EN 13657:2004 + 
EPA 6010C:2007 
EN 13657 specifies methods of digestion with aqua regia. Solutions 
produced by the methods are suitable for analysis e.g. by atomic 
absorption spectrometry (FLAAS, HGAAS, CVAAS, GFAAS), inductively 
coupled plasma emission spectrometry (ICP-OES) and inductive coupled 
plasma mass spectrometry (ICP-MS). The method is applicable to the 
digestion of waste for example for the following elements: Al, Sb, As, B, 
Ba, Be, Cd, Ca, Cr, Co, Cu, Fe, Pb, Mg, Mn, Hg, Mo, Ni, P, K, Se, Ag, S, 
Na, Sr, Sn, Te, Ti, Tl, V, Zn. 
 
EPA 6010C: 2007 is the EPA method for inductively coupled plasma-
atomic emission spectrometry (ICP-AES) used to determine trace 
elements in solution. Digests of sludge, treated biowaste or soil with 
nitric acid or aqua regia are analysed by inductively coupled plasma 
optical emission spectrometry (ICP-OES) using sequential or 
simultaneous optical systems and axial or radial viewing of the plasma. 
The instrument measures characteristic emission spectra by optical 
spectrometry. Analyte species originating in the digest solution are 
nebulised and the resulting aerosol is transported to the plasma torch. 
Element-specific emission spectra are produced by a radio-frequency 
inductively coupled plasma. The spectra are dispersed by a grating 
spectrometer, and the intensities of the emission lines are monitored by 
photosensitive devices. 
The method is equivalent to CEN EN 16170 (2016) 
Ni EN 13657:2004 + 
EPA 6010C:2007 
Pb EN 13657:2004 + 
EPA 6010C:2007 
Cu EN 13657:2004 + 
EPA 6010C:2007 
Zn EN 13657:2004 + 
EPA 6010C:2007 
Hg EN 13657:2004 + 
APAT CNR IRSA 
3200A2 Man. 
29:2003 
K EN 13657:2004 + 
EPA 6010C:2007 
NKjeldahl D.M. 13/09/1999 
GU n° 248 
21/10/1999 Met 
XIV.3 
The dried and homogenised material is digested in a suitable 
Kjeldahltube with sulfuric acid. To rise the temperature potassium sulfate 
is added and titanium dioxid/copper sulfate is used as a catalyst. After 
adding sodium hydroxide to the digestion solution the produced 
ammonium from all nitrogen species is evaporated by distillation as 
ammonia. This is condensed in a conical flask with boric acid solution. 
The amount is titrated against indicator with sulfuric acid. 
The method is equivalent to CEN EN 16169 (2002) 
P D.M. 13/09/1999 
GU n° 248 
21/10/1999 Met 
XV.1 
The sample is treated with sulphuric acid, hydrogen peroxide and 
hydrofluoric acid. Spectrophotometric determination of phosphorous, 
using ascorbic acid procedure. 
No equivalent EU Standard 
 
 
 
3.4 First experimental and analytical results   
3.4.1 Non-processed manure 
Results of triplicate cattle urine analysis according to 5.1 are reported in Table 17. 
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Table 17 – Preliminary results of cattle urine analysis 
Analyte CHEMICAL CLASS Mean Conc (ng/l) St. Dev.  CV% 
Albendazole Benzimidazole dewarmer 45 504.6 23 039.7 50.6 
Enrofloxacin Fluoroquinolone antibiotic 689.2 123.9 18.0 
Erythromycin Macrolide  2 651.9 251.9 9.5 
Clarithrimycin  Macrolide  5.2 1.9 36.0 
Monensin Polyether antibiotic  1 011.1 262.7 26.0 
Oxytetracycline Tetracycline antibiotic 11 669.9 1 728.7 14.8 
Chlorotetracycline 699.8 505.3 72.2 
3.4.2 Processed manure 
Sample preparation for processed manure was characterised in two following steps: 
• an evaluation of the suitability of chosen SPE polymeric phase (i.e.: HLB) for the 
extraction of target analytes form MilliQ water and then  
• a spiking experiment using the real matrix (i.e.: digestate sample) for the 
evaluation of reproducibility in real analytical conditions.  
 
3.4.2.1 Evaluation of suitability of HLB polymeric phase for analytes extraction  
The evaluation of the suitability of chosen polymeric phase for the extraction of target 
analytes was based on a triplicate extraction of each 100 ml MilliQ water spiked samples 
according to the procedure reported at 3.2.  
The spiking level of 1 μg/l for all selected analytes. Table 18 summarises the recovery 
data obtained.  
 
Table 18 - Recovery of selected analytes for MilliQ water spiked samples. 
Analyte   CHEMICAL CLASS Mean REC in 
AcOEt 
Mean REC in 
MeOH 
Total rec of 
sequential 
elution  
Miconazole  Imidazole antifungal drug 19.6 1.7  21.3
Climbazole  140.4 140.4
Ketoconazole  42.6 5.7  48.3
Fluconazole  104.5 0.6  105.0
Albendazole  Benzimidazole dewarmer na na na
Levamisole  Imidazole* dewarmer  na na na
Bronopol  2-bromo-2-nitro-propanediol antimicrobial agent na na na
Amoxicillin b-lactam na na na
Florfenicol  Fluoroacetamide antibiotic  184.3 3.4  187.7
Ofloxacin  Fluoroquinolone antibiotic 5.3 6.3  11.6
Marbofloxacin  2.6 4.9  7.5
Enrofloxacin  4.8 3.2  8.0
Sarafloxacin  1.8 24.5  26.3
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Analyte   CHEMICAL CLASS Mean REC in 
AcOEt 
Mean REC in 
MeOH 
Total rec of 
sequential 
elution  
Roxitrhomycin  Macrolide  1.9  1.9
Erythromycin  1.8  1.8
Clarythromycin  0.0
Diazinon  Organophosphate insecticide 130.1 3.9  134.1
Monensin  Polyether antibiotic  67.2 6.9  74.1
Oxolinic acid  Quinolone antibiotic  138.4 4.9  143.3
Sulfadiazine  Sulfonamide antibiotic 89.6 2.2  91.8
Sulfathiazole  3.9 53.1  57.0
Sulfamethoxazole  106.3 2.5  108.8
Sulfamethazine  132.0 1.8  133.8
Sulfadimethoxine  84.3 6.3  90.6
Oxytetracyclin  Tetracycline antibiotic 65.3 11.1  76.3
Chlorotetracyclin  52.2 69.6  121.7
Toltrazuril  Triazintrione 26.7 1.2  27.9
Simazine  Triazinic herbicide  94.2 3.1  97.3
Trimethoprim  Synthetic derivative of trimethoxybenzyl‐pyrimidine with 
antibacterial and antiprotozoal properties 
65.7 29.9  95.6
 
No recovery resulted for albendazole and levamisole and further improvements are 
needed.  
Low recoveries were obtained for fluoroquinolone and macrolide antibiotic residues. This 
finding did not surprise considering that the pH of spiked samples was not adjusted to 
acidic.  
 
3.4.2.2 Extraction reproducibility in real matrix 
Results of extraction reproducibility in real matrix are summarised in Table 19.  Digestate 
samples were spiked at 10 µg/l.  
The experiment consisted in the triplicate extraction of spiked digestate sample, 
opportunely diluted to 100 ml with MilliQ water, according to the procedure described in 
3.2. 
 
Table 19 - Results of extraction reproducibility in real matrix 
Analyte CHEMICAL CLASS Mean Conc 
(ng/l) 
REC % (vs nominal  
conc.) 
Extraction 
Reproducibility % 
(n=3) 
Miconazole Imidazole antifungal 
drug 
1872.2 18.7 22.5
Climbazole 11416.7 114.2 14.9
Ketoconazole 4704.6 42.8 19.4
Fluconazole 5656.5 56.6 9.9
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Analyte CHEMICAL CLASS Mean Conc 
(ng/l) 
REC % (vs nominal  
conc.) 
Extraction 
Reproducibility % 
(n=3) 
Albendazole Benzimidazole 
dewarmer 
na na na
Levamisole Imidazole* dewarmer  4 049.0 40.5 4.1
Bronopol  2-bromo-2-nitro-
propanediol 
antimicrobial agent  
na na na
Amoxicillin b-lactam na na na
Florfenicol Fluoroacetamide 
antibiotic  
8 244.7 82.4 3.6
Ofloxacin Fluoroquinolone 
antibiotic 
3 051.6 30.5 41.7
Marbofloxacin  2 514.5 21.0 64.3
Enrofloxacin 3 292.7 27.4 35.9
Sarafloxacin 1 2 050.6 20.5 14.5
Roxithromycin  Macrolide  632.9 6.3 40.5
Erythromycin 7 807.6 73.7 11.7
Clarithrimycin  707.7 3.5 69
Diazinon Organophosphate 
insecticide 
16 098.3 123.8 2.7
Monensin Polyether antibiotic  7 371.8 73.7 66.3
Oxolinic acid Quinolone antibiotic  21 311.1 236.8 4.4
Sulfadiazine Sulfonamide antibiotic 1 179.0 11.8 14.8
Sulfathiazole 2 738.4 21.1 22
Sulfamethoxazole 7 954.2 38.5 16.5
Sulfamethazine 3 941.7 19.2 2.1
Sulfadimethoxine 2 893.3 26.3 47.3
Oxytetracycline Tetracycline antibiotic na na na
Chlorotetracycline na na na
Toltrazuril Triazintrione 16 597.9 166.0 9.8
Simazine  Triazinic herbicide 5 275.3 48.4 18.3
Trimethoprim Synthetic derivative of 
trimethoxybenzyl-
pyrimidine with 
antibacterial and 
antiprotozoal properties 
6 519.0 74.8 24.6
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3.4.2.3 Results of processed manure analysis  
Results of positive finding in the analysis of processed manure are reported in Table 19. 
 
Table 20 - Results of processed manure analysis 
Processed manure (Digestate) 
 
Mean Conc (ng/l) St. Dev. CV% 
Analyte CHEMICAL CLASS 
Miconazole Imidazole antifungal drug 109.03 36.2 33.2
Climbazole 13.25 6.4 48.6
Fluconazole 16.07 2.0 12.5
Diazinon Organophosphate insecticide 93.29 13.2 14.1
Monensin Polyether antibiotic  785.15 210.9 26.9
Quinoxyfen  Fungicide (Dichloro -
fluorophenoxyquinoline) 
634.4 79.9 12.6 
 
Test results obtained by the commercial laboratory are summarised in Table 21. Original 
certificates of analyses are available upon request. 
 
Table 21 – Results of inorganic characterisation of two independent digestate samples 
Parameter Results 
(Sample 1 and 2) 
Unit Reported uncertainty 
in rel.% 
Dry matter content at 
105°C 
2.1 
2.1 
Wgt.% 12 
Loss on ignition 600°C 0.6 
0.7 
Wgt.% 8 
Total organic carbon 5 834 
5 963 
mg/l 12.5 
Cr VI <0.5 
<0.5 
mg/l 20 
Cd <0.04 
<0.03 
mg/l 11 
Ni <0.04 
<0.03 
mg/l 15 
Pb 0.12 
0.06 
mg/l 17 
Cu 0.50 
0.44 
mg/l 14 
Zn 3.40 
2.88 
mg/l 17 
Hg <0.01 
<0.01 
mg/l 19 
K 17.1 
15.8 
mg/l 16 
NKjeldahl 392 
297 
mg/l 15 
P 119 
165 
mg/l 13.5 
Sample 1 – Identifier: 0062_MA_17072_00_00 MANURE 2 SLOVAKIA 
Sample 2 – Identifier: 0062_MA_17073_00_00 MANURE 3 SLOVAKIA 
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4 Preliminary conclusions and next steps 
The primary objective of this first exploration was the development of a realistic sampling 
scenario in view of a larger EU-wide campaign. Indeed, the testing site operated by the 
Agricultural University of Nitra (AUN), its availability in terms of geographical position 
and infrastructures demonstrated to be a suitable example of an experimental site for 
future official EU-wide manure monitoring campaign.  
In addition, availability of information on manure application techniques, weather data, 
farming and livestock were shared timely. This constitutes an essential element in 
streamlining subsequent data interpretation and the planning of further experimental 
activities.  
Furthermore, the testing site granted access to surface ditches and groundwater wells for 
water sample collection. These aspects could not be fully exploited in this first reporting. 
First operative findings and field test proved the full applicability of the MARIANI-Box 
even under extreme field and sampling conditions. It could indeed be shown that it is 
possible to collect additional information on manure properties, the agricultural context 
and the receiving water bodies combining traditional sampling with the SPE features of 
the box. To which extent information on anti-microbial resistances can be obtained is still 
to be discovered while analytical determinations are still ongoing. It can be anticipated, 
that the handling of large scale sampling volumes of several litres will be challenging, if 
not impossible in such a campaign. A “microbiological” adaptation of the Mariani-Box, 
which would allow for similar, microbiological imprinting or field-based extraction is an 
idea to be explored further. 
In addition, it was attempted to answer the question whether a (semi)quantitative 
relationship between the veterinary medicinal application and the occurrence of the 
targeted compounds can be established. First preliminary result, indicate indeed a very 
close relationship between active pharmaceutical ingredients (API) applied to specific and 
individual animals and, on the other side, a very significant concentration in the applied 
manure.  In order to establish quantitative estimates, e.g. defining percentages of 
applied APIs, which finally reach (aquatic) ecosystems, the analytical methods needs to 
be refined further and eventually validated according to the requirements of ISO 17025. 
The third aspect of this first exploration was to lay down a basis for the development of 
an analytical approach for a multi-compound method possibly addressing also a non-
target approach. The analytical procedures reported in the present report demonstrate to 
be a consistent starting point in terms of  
• Suitability of chosen polymeric phase for analytes’ extraction and quantification.  
• Reproducibility both in the analysis of non-treated and treated manure samples.  
Further procedural improvements are obviously needed but these preliminary analytical 
evidences do constitute a considerable basis for future analytical method validations. 
An unexpected side aspect was the opportunity to retrieve also analytical information 
contributing to better evaluate the agronomic value and fertilizing characteristics of the 
(processed) manure. Provided that a sufficiently good data density covering the major 
techniques listed in the introduction part of the paper can be obtained, the envisaged EU-
wide campaign will retrieve a unique data set answering this question. 
Part 2 of this report will address analytical aspects of the water samples. An instruction 
manual for the box in an EU-wide campaign is shown in the annex of this report. A call 
for participation will be published in the forthcoming weeks. 
The exploratory investigations undertaken in this first campaign proofed an EU-wide 
exercise on VMPs in processed manure and exposed waters viable and feasible. 
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List of abbreviations and definitions 
2,4-D  2,4-Dichlorophenoxyacetic acid 
2,4,5-T  2,4,5-Trichlorophenoxyacetic acid 
4-t-OP  4-Tert-octylphenol 
AMA  anti-microbial agent 
API  active pharmaceutical ingredient 
CEC  compounds of emerging concern 
DEET  N, N-Diethyl-meta-toluamide 
D.M.  dry matter 
E1  Estrone 
E2  Estradiol 
EE2  Ethinylestradiol 
EQS  Environmental Quality Standard 
EC  European Commission 
EMA  European Medicines Agency 
EU  European Union 
HBCD  Hexabromocyclododecane 
I.S.  Internal Standard 
ISO  International Standardization Organization 
IUPAC  International Union for Pure and Applied Chemistry 
JRC  Joint Research Centre 
MCPA  2-methyl-4-chlorophenoxyacetic acid 
MeOH  methanol 
ml  millilitre 
MRM  multiple reaction monitoring 
MS  mass spectrometer 
μg  microgram 
ND  Nitrates Directive 
ng  nanogram 
NVZ  Nitrates Vulnerable Zones 
PFBA  Perfluorobutanoic acid 
PFBS  nonafluoro-1-butanesulfonic acid 
PFHxA  perfluorohexanoic acid 
PFHxS  Perfluorohexane sulfonate 
PFNA  Perfluorononanoic acid 
PFOA  Perfluorooctanoic acid 
PFOS  Perfluorooctanesulfonic acid 
PP  polypropylene 
PPG  polypropylene glycol 
SMZ  sulfamethazine 
VMP  veterinary medicinal product 
 
All country names are abbreviate using the ISO “Alpha 2 codes” 
Chemical elements are expressed using IUPAC Nomenclature rules 
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Annexes 
Annex 1. MARIANI Box - Instructions for use 
 
INSTRUCTIONS 
FOR USE 
 
Dear Colleagues, 
You received one parcel containing the Mariani Box sampling device and a cooling bag with cooling 
bricks. 
Inside the Mariani Box you can find:  
• DVD containing instruction video,  
• Instruction sheet (present document),  
• 2 sampling bill sheets  
• 3 filter holders containing activated disk for extraction (DO NOT OPEN)  
• 1 battery charger,  
• 2 x 3mt PTFE tubes 
• Male-male Luer-Lock connector. 
• Power plug adapter 
 
We suggest freezing immediately the cooling bricks in order to have them frozen when necessary. 
In order to avoid possible cross contamination between samples, we recommend proceeding first 
with extraction of less contaminated sample (i.e.: effluent), followed by the extraction of influent 
sample, which likely would exhibits higher level of concentration of contaminants.  
 
Description of sampling device 
The Mariani box consists in the following parts: 
1. Holder SPE disk 
2. Flow meter  
3. Counter  
4. Pump (Flow rate 0.1-0.2 l/min) 
5. Battery  
6. Water sampling line 
7. Waste line 
 
Each holder contains HLB disk ready for sampling. Use one holder for each sample.  
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Connect the holder to the pump according to sides’ definitions (↑ upper side; ↓ bottom side). 
Luer-Lock openings located on upper and bottom side of the holder will host PFTE tubes for 
sampling.  
Please fill in the sampling bill with requested information before starting sampling and register site, 
date and time of sampling on the holder, too. 
 
 
Operations 
From this section onwards, please refer to the more detailed picture reported below:  
 
 
 
Once on site, open the box and blocks the opening by fixing the metal shaft (1). 
 
• Connect the waste line: unscrew the Luer-Lock cap from the bottom side of the holder and 
connect it to position 3a, screwing gently; remove Luer-Lock caps from the upper side of 
the holder and insert the 3 mt PTFE tube. Tighten screwing gently both connections 
(respectively 3a and 3b) and fix the waste line (3b) with the metal shaft (4).  
• Connect the sampling line: screw the second 3 mt PTFE tube into the Luer-Lock connection 
placed in 5.  
• Register the starting reading of the counter (6);  
• Connect the battery cable (red positive and black negative (7)) 
• Turn on the device pushing the red switch (8). 
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At this point the system start to pump the water sample from the sampling point 
(influent/effluent).  
The water will pass through the sampling line (5), the flow meter, the pump and finally in the 
holder, where HLB disk is located. 
When 0.5 l volume is sampled (read the sample volume on the counter (6)), keep out of water the 
water sampling line (5) and wait for all water in the tubes and in holder being expelled. 
• Turn off the device when the waste line is completely empty (8). 
• Register the final reading of the counter (6);  
 
Holder for blank sample, must be on site during sampling, without any processing.  
After extraction, the holder must be removed from the sampling device and the Luer-Lock 
connections must be closed with their original caps. Samples must be stored at 4-6°C and in 
cooling bag with frozen cooling bricks.  
At the end of sampling, please coil the PTFE tubes and put together all spare parts in their 
dedicated spaces inside the box. 
 
Cleaning  
After each sampling, cleaning PTFE tubes and pump will avoid cross-contamination.  
The same cleaning procedure must be performed after last sample extraction.  
Using the male-male Luer-Lock connection provided, placed in place of the holder, pass through 
the system about 1 liter of clean water (i.e.: distilled, MilliQ water, etc.). Please use a clean 
container for the water. 
ONLY if distilled and or MilliQ water were not available use tap water. 
 
Sample storage  
Environmental water samples extracted on SPE disks can be stored at in the fridge at 4°C until 
pick-up by JRC service. 
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